Equinix — Apr 30, 2025 release

This $142 million increase from previously issued guidance is due to a $135 million foreign currency benefit when compared to the prior guidance rates and $7 million better-than-expected Q1 performance. Adjusted EBITDA is expected to range between $4.471 and $4.551 billion, an adjusted EBITDA margin of 49%, an approximate 210 basis-point expansion over the previous year. This $85 million increase from previously issued guidance is due to a $78 million foreign currency benefit when compared to prior guidance rates and $7 million of better-than-expected Q1 operating performance. AFFO is expected to range between $3.675 and $3.755 billion, an increase of 9 - 12% over the previous year on both an as-reported and a normalized and constant currency basis. This $69 million increase from previously issued guidance is due to a $52 million foreign currency benefit when compared to prior guidance rates and $17 million better-than-expected Q1 operating performance. AFFO per share is expected to range between $37.36 and $38.17, an increase of 7 - 9% over the previous year on both an as-reported and a normalized and constant currency basis. Total capital expenditures are expected to range between $3.426 and $3.676 billion. Non-recurring capital expenditures, including xScale-related capital expenditures, are expected to range between $3.168 and $3.398 billion, and recurring capital expenditures are expected to range between $258 and $278 million. The U.S. dollar